What recession? Pfizer $PFE stock offers up healthy Q2 on covid drug outperformance
, Pfizer showed it hadn't noticed. The pharmaceutical giant offered up $2.04 in adjusted earnings per share that blew past expectations by $0.26. In other words, Pfizer beat analyst consensus by nearly 15%. Revenue then came in at $27.7 billion, which was also well ahead of forecasts by $1.5 billion.Amazon Stock Deep Dive: AMZN price target at $106 with near-term risks offset by long-term growthis surprisingly down after blowing past its Q2 earnings expectations. Shares are off 4.1% to $49.
that the lower limit to full-year EPS was being raised by $0.24 and full-year revenue by $2 billion in constant currency terms. When currency fluctuations are taken into account ,and that EPS will only add $0.05 to the prior lower end of guidance . The Moving Average Convergence Divergence is barely moving. Look for the MACD to wake up before there is any real movement. For now, it looks likeInformation on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Pfizer loses court battle over drug copay assistance program with big implications for Medicare spendingIn a lawsuit against the government, Pfizer sought a legal go-ahead for a proposed program that would help cover copays for Medicare patients taking a heart drug priced at $225,000 a year.
Baca lebih lajut »
As more people report Paxlovid rebounds of Covid, experts insist the cases are rareAround 1-2% of people taking Paxlovid in Pfizer's clinical trial tested positive for the coronavirus after testing negative. Rebound rates are around 5% among the tens of thousands of people who've taken the drug in real-life settings.
Baca lebih lajut »
Smoking, vaping increases risk of death from COVID, study findsA new study finds that smoking and vaping prior to hospitalization from COVID-19 increases the risk of severe illness and death from COVID-19.
Baca lebih lajut »
New Study Suggests How Frequently Long COVID May Happen In KidsThe findings offer clues as to how often post-COVID symptoms occur in young people, and what the risk factors may be.
Baca lebih lajut »
Mom sues LAUSD after she says son was vaccinated without her consent, suffered side effectsThe mother claims her son was offered a piece of pizza in exchange for a COVID shot and then allegedly coerced into forging his mom's signature.
Baca lebih lajut »
Brands must appeal to disparate consumer causes, financial anxietiesAfter experiencing the COVID-19 pandemic, navigating stock market volatility and witnessing global strife, American consumers have a lot on their plate.
Baca lebih lajut »